Life Sciences

Ajax Therapeutics, Inc. Appoints Dr. David Steensma as Chief Medical Officer
Ajax Therapeutics, Inc. announced the appointment of David P. Steensma as Chief Medical Officer. Dr. David, a renowned expert in hematologic malignancies, has more than 25 years of experience and was formerly the Global Head of Hematology at Novartis Institutes for Biomedical Research, where he led early clinical development in...
August 2023
Mouse Scroll Icon